Safety of treatment and dietary supplementation with diosmin in daily doses up to 2000 mg a day
Journal Title: New Medicine - Year 2016, Vol 20, Issue 3
Abstract
Introduction. diosmin is used to treat and alleviate the symptoms of venous insufficiency and haemorrhoids. diosmin-containing medicinal products have been available in poland since the 1990s with the status of drugs available on prescription in the form of flavonoid fraction containing diosmin, as a form subjected to micronisation or nonmicronised. for several years now, diosmin has been present on the pharmaceutical market in the form of over-the-counter medicines (otC), and dietary supplements containing diosmin are available not only in pharmacies, but also in other outlets. great availability of diosmin raises questions about the safety of a treatment without medical or pharmacist’s supervision. the safety of diosmin use in a daily dose of 2000 mg was confirmed in a double-blind, controlled placebo, randomised, three-arm and parallel, phase iii to evaluate the efficacy and safety of diosmin administered for 4 months in the treatment of cellulite. Aim. the aim of the study was to observe the efficacy and safety of micronised diosmin therapy used in a daily dose of 1000 and 2000 mg for a period of four months. Material and methods. the trial involved 327 patients aged 18 to 55 (mean 37.28, standard deviation of 8.587) meeting the inclusion criteria and not meeting the exclusion criteria. the safety analysis includes and shows in a table the measured parameters immediately prior to the first dose, after 2 and 4 months of therapy. Results. no statistically significant deviations from the standard condition in the following parameters present: complete blood count with differential, fibrinogen concentrations, alanine and aspartate transaminase concentration, urea and creatinine concentration, urinalysis. the therapy did not affect the value of systolic and diastolic blood pressure. no significant adverse actions in the studied groups. Conclusions. the results of a clinical trial cited in this work support the use of micronised diosmin in doses up to 2000 mg per day.
Authors and Affiliations
Agnieszka Staniewska
Keywords
Related Articles
- EP ID EP188106
- DOI -
- Views 103
- Downloads 0
Applying the network research matrix methodology to identify and map the international migration of hungarian nurses
Nurse migration (like migration in general) is a complex and dynamic process and there are no simple and painless ways to draw a clear picture about it. In the course of the analysis, however, I have discovered a new lin...
Financial Status Of Patients With Chronic Musculoskeletal Diseases And Limited Working Ability
Aim. The aim of the study was to assess the financial status and perspectives of patients with chronic musculoskeletal diseases and limited working ability.Patients. 200 inpatients under rheumatology rehabilitation in th...
Congenital absence of the right pulmonary artery rare casuse of radiological changes suggestive of bronchial foreign body
We report the case of 6.5 year old girl admitted to the Department of Pediatric ENT in Warsaw Medical University in January 2013 suspected of the foreign body in the right bronchus because of the characteristic signs on...
Effects of assisted reproductive treatments on pregnant women’s mental health
Introduction. Childbirth is one of the most important period in women’s life. It gets an even bigger emphasis, if parents have to take some kind of assisted reproductive treatment for the conception. The number of cases...
William Ernest Miles – twórca radykalnej metody operacji raka odbytnicy